Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > BUSINESS
BUSINESS
- Shonan Health Innovation Park Marks Grand Opening: Takeda
April 16, 2018
- Oncodesign Partners with Erytech to Support Preclinical Development of Anticancer Drugs
April 16, 2018
- Mylan Gets EU Rights for Fujifilm Kyowa Kirin Biologics’ Humira Biosimilar
April 12, 2018
- Chugai Drops Patent Suit over Nippon Kayaku’s Herceptin Biosimilar
April 12, 2018
- Japan Ethical Drug Sales Total 9.9 Trillion Yen in FY2017: Encise Snapshot
April 11, 2018
- Mitsubishi Tanabe’s ALS Drug Filing Accepted for Review in Canada
April 11, 2018
- Takeda Carve-Out Venture Boots Up with 250 Million Yen Seed Round
April 11, 2018
- Hisamitsu’s Japan Ethical Drug Sales Down 3.1% in FY2017
April 11, 2018
- Mitsubishi Tanabe Files with International Court for Upfront Payment Return from S. Korean Firm
April 11, 2018
- Osaka Univ. Spinout, Sumitomo Dainippon Strike Option Deal on Antibody-Inducing Peptides
April 10, 2018
- Otsuka Partners with Takara Bio to Codevelop Gene Therapy Products with Exclusive Sales Rights in Japan
April 10, 2018
- Ethical Drug Sales Up 1.0% in February: Crecon Report
April 9, 2018
- Kowa Gets High Court Backing in Livalo Patent Suit
April 9, 2018
- Alfresa to Fully Introduce Distribution Cost Analysis System; Will “Raise Reps’ Awareness of Importance of Price Negotiations”: Pres.
April 9, 2018
- Japan Generic Market Projected at 1.2 Trillion Yen in 2021: Fuji Keizai
April 6, 2018
- Takeda, DNDi to Collaborate in Visceral Leishmaniasis Drug Development
April 6, 2018
- Daiichi Sankyo Expands Cancer Collaboration with DarwinHealth
April 6, 2018
- Takeda to Divest Its Brazilian OTC, Gx Subsidiary to Local Pharma
April 6, 2018
- Zyprexa Generics Now Carry Same Indications as Originator
April 5, 2018
- Nebulized COPD Med Lonhala Magnair Now Available in US: Sunovion
April 5, 2018
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…